A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled GDC-0214, a JAK1 Inhibitor, as Single- and Multiple-Ascending Doses in Healthy Volunteers

被引：0

作者：

Owen, Ryan ^{[1
]}

Galanter, Joshua ^{[2
]}

Zhu, Rui ^{[2
]}

Cai, Fang ^{[2
]}

Tom, Jennifer ^{[2
]}

Wynne, Chris ^{[3
]}

Durk, Matthew ^{[2
]}

Chen, Liuxi ^{[2
]}

Kenny, Jane ^{[2
]}

She, Gao-hong ^{[2
]}

Vadhavkar, Shweta ^{[2
]}

Hwang, Olivia ^{[2
]}

Chen, Hubert ^{[2
]}

机构：

[1] Genentech Inc, San Francisco, CA USA

[2] Genentech Inc, San Francisco, CA 94080 USA

[3] Christchurch Clin Studies Trust, Christchurch, New Zealand

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2020年 / 145卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

052

引用

页码：AB17 / AB17

页数：1

共 50 条

[21] Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers
Rothenberg, Michael E.
Tagen, Michael
Chang, Jae H.
Boyce-Rustay, Janel
Friesenhahn, Michel
Hackos, David H.
Hains, Avis
Sutherlin, Dan
Ward, Michael
Cho, William
CLINICAL DRUG INVESTIGATION, 2019, 39 (09) : 873 - 887
[22] A First-in-Human Single- and Multiple-Ascending Dose Study Evaluating Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Oral Nonpeptide GLP-1 Receptor Agonist in Healthy Subjects
Pratt, Edward J.
Ma, Xiaosu
Liu, Rong
Robins, Deborah A.
Sloop, Kyle
Benson, Charles
DIABETES, 2022, 71
[23] A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
Laties, Alan
Rich, Cadmus C.
Stoltz, Randall
Humbert, Vernon
Brickman, Chaim
McVicar, William
Baumgartner, Rudolf A.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 32 (08) : 548 - 554
[24] A Phase 1 study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9161 in Chinese healthy volunteers
Yap, D.
Zhou, X.
Chen, X.
Lee, M.
Zhang, Y.
Wang, M.
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1178 - 1179
[25] Phase 1 Dose-Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Japanese Healthy Volunteers
Miyoshi, So
Krishnaswami, Sriram
Toyoizumi, Shigeyuki
Nakamura, Hiroyuki
Zwillich, Samuel H.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (01): : 11 - 20
[26] A PHASE 1 MULTIPLE ASCENDING DOSE (MAD) STUDY OF INCB054707, A JAK1 INHIBITOR, IN HEALTHY PARTICIPANTS.
Gong, X.
Chen, X.
Xun, Z.
Liu, X.
Wang, P.
Yeleswaram, S.
Punwani, N.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S22 - S22
[27] A PHASE 1 SINGLE ASCENDING DOSE (SAD) STUDY OF INCB054707, A JAK1 INHIBITOR, IN HEALTHY PARTICIPANTS.
Gong, X.
Chen, X.
Xun, Z.
Liu, X.
Wang, P.
Yeleswaram, S.
Punwani, N.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S22 - S22
[28] Safety, pharmacokinetics, and pharmacodynamics of ascending multiple oral doses of a new protease activated receptor-1 inhibitor in healthy volunteers
Marion, A.
Reyes, J.
Chen, H.
Wittek, A.
JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1085 - 1085
[29] Safety, Tolerability, and Pharmacokinetics of Intravenous Oseltamivir: Single- and Multiple-Dose Phase I Studies with Healthy Volunteers
Brennan, Barbara J.
Davies, Brian
Cirrincione-Dall, Georgina
Morcos, Peter N.
Beryozkina, Anna
Chappey, Colombe
Baldo, Pau Aceves
Lennon-Chrimes, Sian
Rayner, Craig R.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (09) : 4729 - 4737
[30] A Phase 1 Single and Multiple Ascending Dose (SAD/MAD) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AV-101, a Novel Inhaled Dry Powder Formulation of Imatinib in Healthy Subjects
Gillies, H.
Niven, R.
Dake, B.
Chakinala, M. M.
Feldman, J. P.
Hill, N. S.
Hoeper, M.
Humbert, M. J.
Mclaughlin, V. V.
Kankam, M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205

← 1 2 3 4 5 →